SEARCH

SEARCH BY CITATION

References

  • ARCECI, R.J., KING, A.A.J., SIMO, M.C., ORKIN, S.H. & WILSON, D.B. (1993). Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol. Cell. Biol., 13, 22352246.
  • ARDATI, A. & NEMER, M. (1993). A nuclear pathway for α1-adrenergic receptor signaling in cardiac cells. EMBO J., 12, 51315139.
  • ARGENTIN, S., ARDATI, A., TREMBLAY, S., LIHRMANN, I., ROBITAILLE, L., DROUIN, J. & NEMER, M. (1994). Development stage-specific regulation of atrial natriuretic factor gene transcription in cardiac cells. Mol. Cell. Biol., 14, 777790.
  • BACHILLER, D. & RUTHER, U. (1990). Inducible expression of the proto-oncogene c-fos in transgenic mice. Archiv fur Geschwulstforschung, 60, 357360.
  • BARKA, T., VAN DER NOEN, H. & SHAW, P.A. (1987). Proto-oncogene fos (c-fos) expression in the heart. Oncogene, 1, 439443.
  • BÖHN, M., CASTELLANO, M., AGABITI-ROSEI, E., FLESCH, M., PAUL, M. & ERDMANN, E. (1995). Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and β-adrenergic signal transduction. Circ., 92, 30063013.
  • BÖHM, M., MOLL, M., SCHMID, B., PAUL, M., GANTEN, D., CASTELLANO, M. & ERDMANN, E. (1994). β-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hypertension, 24, 653662.
  • BOLUYT, M.O., LONG, X., ESCHENHAGEN, T., MENDE, U., SCHMITZ, W., CROW, M.T. & LAKATTA, E.G. (1995). Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am. J. Physiol., 269, H638H647.
  • BRAND, T., SHARMA, H.S. & SCHAPER, W. (1993). Expression of nuclear proto-oncogenes in isoproterenol-induced cardiac hypertrophy. J. Mol. Cell. Cardiol., 25, 13251337.
  • BUU, N.T., HIU, R.T. & FALARDEAU, P. (1993). Norepinephrine in neonatal rat ventricular myocytes: Association with the cell nucleus and binding to nuclear α1- and β-adrenergic receptors. J. Mol. Cell. Cardiol., 25, 10371046.
  • CASSIDY, S.C., MCGOVERN, J.J., CHAN, D.P. & ALLEN, H.D. (1997). Effects of commonly used adrenergic agonists on left ventricular function and systemic vascular resistance in young piglets. Am. Heart J., 133, 174183.
  • CHEN, C.Y., CROISSANT, J., MAJESKY, M., TOPOUZ, S., MCQUINN, T., FRANKOVSKY, M.J. & SCHWARTZ, R.J. (1996). Activation of the cardiac alpha-actin promoter depends upon serum response factor, Tinman homologue, Nkx2-5, and intact serum response elements. Dev. Genet., 19, 119130.
  • CHIRGWIN, J.M., PRZYBULA, A.E., MACDONALD, R.J. & RUTTER, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochem., 18, 52945299.
  • DUROCHER, D., CHARRON, F., WARREN, R., SCHWARTZ, R.J. & NEMER, M. (1997). The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J., 16, 56875696.
  • DUROCHER, D., CHEN, C.-Y., ARDATI, A., SCHWARTZ, R.J. & NEMER, M. (1996). The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. Mol. Cell. Biol., 16, 46484655.
  • GANDARILLAS, A. & WATT, F.M. (1995). Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinocytes. Oncogene, 11, 14031407.
  • GASHLER, A. & SUKHATME, V.P. (1995). Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucl. Acids Res., 50, 191224.
  • GOLOMB, E., ABASSI, Z.A., CUDA, G., STYLIANOU, M., PANCHEL, V.R., TRACHEWSKY, D. & KEISER, H.R. (1994). Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am. J. Physiol., 267, H14961506.
  • GRÉPIN, C., DAGNINO, L., ROBITAILLE, L., HABERSTROH, L., ANTAKLY, T. & NEMER, M. (1994). A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol. Cell. Biol., 14, 31153129.
  • GUPTA, M.P., GUPTA, M., ZAK, R. & SUKHATME, V.P. (1991). Egr-1, a serum-inducible zinc finger protein, regulates transcription of the rat cardiac α-myosin heavy chain gene. J. Biol. Chem., 266, 1281312816.
  • GUYTON, A.C. (1992). Kidneys and fluids in pressure regulation; small volume but large pressure changes. Hyperten., 19, 1218.
  • HANNAN, R.D. & WEST, A.K. (1991). Adrenergic agents, but not triiodo-1-thyronine induce c-fos and c-myc expression in the heart. Basic Res. Cardiol., 86, 154164.
  • HERZIG, T.C., JOBE, S.M., AOKI, H., MOLKENTIN, J.D., COWLEY, JR A.W. & ARKHAM, B.E. (1997). Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc. Natl. Acad. Sci. U.S.A., 94, 75437548.
  • HOLDER, E.L., AL MOUSTAFA, A.-E. & CHALIFOUR, L.E. (1995). Molecular remodeling in hypertrophied hearts from polyomavirus large T-antigen transgenic mice. Mol. Cell. Biochem., 152, 131141.
  • HUANG, R.P., FAN, Y., NI, Z., MERCOLA, D. & ADAMSON, E.D. (1997). Reciprocal modulation between Sp1 and Egr-1. J. Cell. Biochem., 66, 489499.
  • IP, H.S., WILSON, D.B., HEIKINHEIMO, M., TANG, Z., TING, C.N., SIMON, M.C., LEIDEN, J.M. & PARMACEK, M.S. (1994). The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells. Mol. Cell. Biol., 14, 75177526.
  • IWAKI, K., SUKHATME, V.P., SHUBEITA, H.E. & CHIEN, K.R. (1990). Alpha- and beta-adrenergic stimulation induced distinct patterns of immediate early gene expression in neonatal rat myocardial cells. Fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response. J. Biol. Chem., 265, 1380913817.
  • JOHN, S.W.M., KREGE, J.H., OLIVER, P.M., HAGAMAN, J.R., HODGIN, J.B., PANG, S.C., FLYNN, T.G. & SMITHIES, O. (1995). Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science, 267, 679681.
  • JOHNSON, R.S., LINGEN, B.V., PAPAIOANNOU, V. & SPIEGELMAN, B.M. (1993). A null mutation at the c-Jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev., 7, 13091317.
  • KHACHIGIAN, L.M. & COLLINS, T. (1997). Inducible expression of Egr-1 dependent genes. A paradigm of transcriptional activation in vascular endoethelium. Circ. Res., 81, 457461.
  • KITSIS, R.N. & LEINWAND, L.A. (1992). Discordance between gene regulation in vitro and in vivo. Gene Expression, 2, 313317.
  • KOBILKA, B. (1993). Adrenergic and muscarinic receptors of the heart. In Molecular Basis of Cardiology. ed. Roberts, R. pp. 211238. London: Blackwell Scientific Publications.
  • KOVACIC-MILIVOJEVIC, B., WONG, V.S.H. & GARDNER, D.G. (1996). Selective regulation of the atrial natriuretic peptide gene by individual components of the activator protein-1 complex. Endocrinology, 137, 11081117.
  • KUO, C.T., MORRISEY, E.E., ANANDAPPA, R., SIGRIST, K., LU, M.M., PARMACEK, M.S., SOUDAIS, C. & LEIDEN, J.M. (1997). GATA-4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev., 11, 10481060.
  • KURABAYASHI, M., KOMURO, I., SHIBASAKI, Y., TSUCHIMOCHI, H., TAKAKU, F. & YAZAKI, Y. (1990). Functional identification of the transcriptional regulatory elements within the promoter region of the human ventricular myosin alkali light chain gene. J. Biol. Chem., 265, 1927119278.
  • LAYCOCK, S.K., KANE, K.A., MCMURRAY, J. & PARRATT, J.R. (1996). Captopril and norepinephrine-induced hypertrophy and haemaodynamics in rats. J. Cardiovasc. Pharmacol., 27, 667672.
  • LAYCOCK, S.K., MCMURRAY, J., KANE, K.L. & PARRAT, J.R. (1995). Effects of chronic norepinephrine administration on cardiac function in rats. J. Cardiovasc. Pharmacol., 26, 584589.
  • LEE, R.T., BLOCH, K.D., PFEFFER, J.M., PFEFFER, M.A., NEER, E.J. & SEIDMAN, C.E. (1988). Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J. Clin. Invest., 81, 431434.
  • LEE, S.L., TOURTELLOTTE, L.C., WESSELSCHMIDT, R.L. & MILBRANDT, J. (1995). Growth and differentiation proceeds normally in cells deficient in the immediate early gene NGFI-A. J. Biol. Chem., 270, 99719977.
  • LIEBERMANN, D.A. & HOFFMAN, B. (1998). MyD genes in negative growth control. Oncogene, 17, 33193329.
  • LIU, C., RANGNEKAR, V.M., ADAMSON, E. & MERCOLA, D. (1998). Suppression of growth and transformation and induction of apoptosis by Egr-1. Cancer Gene Therapy, 5, 318.
  • LORD, K.A., ABDOLLAHI, A., HOFFMANN-LIEBERMANN, B. & LIEBERMANN, D.A. (1993). Proto-oncogenes of the fos/jun family of transcripton factors are positive regulators of myeloid differentiation. Mol. Cell. Biol., 13, 841851.
  • LYONS, I., PARSONS, L.M., HARTLEY, L., LI, R., ANDREWS, J.E., ROBB, L. & HARVEY, R.P. (1995). Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx-2.5. Genes Dev., 9, 16541666.
  • MILANO, C.A., ALLEN, L.F., ROCKMAN, H.A., DOLBER, P.C., MCMINN, T.R., CHIEN, K.R., JOHNSON, T.D., BOND, R.A. & LEFKOWITZ, R.J. (1994). Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor. Science, 264, 582586.
  • MILS, V., PIETTE, J., BARETTE, C., VEYRUNE, J.-L., TESNIERE, A., ESCOT, C., GUILHOU, J.-J. & BASSET-SEQUIN, N. (1997). The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene, 14, 15551561.
  • MITCHELL, G.F., PFEFFER, M.A., FINN, P.V. & PFEFFER, J.M. (1996). Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. Circ., 94, 29232929.
  • MOLKENTIN, J.D., KALVAKOLANU, D.V. & MARKHAM, B.E. (1994). Transcription factor GATA-4 regulates cardiac muscle-specific expression of the α-myosin heavy chain gene. Mol. Cell. Biol., 14, 49474957.
  • MOLKENTIN, J.D., LIN, Q., DUNCAN, S.A. & OLSON, E.N. (1997). Requirement of the transcription factor GATA-4 for heart tube formation and morphogenesis. Genes Dev., 11, 10611072.
  • MOLKENTIN, J.D., LU, J.-R., ANTOS, C.L., MARKHAM, B., RICHARDSON, J., ROBBINS, J., GRANT, S.R. & OLSON, E.N. (1998). A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell, 93, 215228.
  • OSAKI, J., HANEDA, T., SAKAI, H. & KIKUCHI, K. (1997). cAMP-mediated c-fos expression in pressure-overloaded acceleration of protein synthesis in adult rat heart. Cardio. Res., 33, 631640.
  • ÖSTMAN-SMITH, I. (1981). Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy. Clin. Science, 61, 265272.
  • PANTERNE, B., HATZFELD, J., BLANCHARD, J.-M., LEVESQUE, J.-P., BERTHIER, R., GINSBURG, M. & HATZFELD, A. (1992). c-Fos mRNA constitutive expression by mature human megakaryocytes. Oncogene, 7, 23412344.
  • POLLAK, P.S. (1995). Proto-oncogenes and the cardiovascular system. Chest, 107, 826835.
  • RAUSCHER III, F.J., VOULALAS, P.J., FRANZA JR, B.R. & CURRAN, T. (1988). Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev., 2, 16871699.
  • REDDY, D.S., SINGH, M. & GANGULY, N.K. (1996). Effects of long-term hydralazine treatment on myocardial structure and expression of myosin isogenes in cardiac pressure overload in rats. Exp. Clin. Pharmacol., 18, 261271.
  • ROCKMAN, H.A., KOCH, W.J. & LEFKOWITZ, R.J. (1997). Cardiac function in genetically engineered mice with altered adrenergic receptor signalling. Am. J. Physiol., 272, H1553H1559.
  • ROSENWEIG, A., HALAZONETIS, T.D., SEIDMAN, J.G. & SEIDMAN, C.E. (1991). Proximal regulatory domains of rat atrial natriuretic factor gene. Circ., 84, 12561265.
  • RUTHER, U., KOMITOWSKI, D., SCHUBERT, F.R. & WAGNER, E.F. (1989). C-fos expression induces bone tumors in transgenic mice. Oncogene, 4, 861865.
  • SAADANE, N., ALPERT, L. & CHALIFOUR, L.E. (1999). TAFII250, Egr-1, and D-type cyclin expression in mice and neonatal rat cardiomyocytes treated with doxorubicin. Am. J. Physiol., 276, H803H814.
  • SAEZ, E., RUTBERG, S.E., MUELLER, E., OPPENHEIM, H., SMOLUK, J., YUSPA, S.H. & SPIEGELMAN, B.M. (1995). c-Fos is required for malignant progression on skin tumors. Cell, 82, 721732.
  • SCHNEIDER, M.D. & PARKER, T.G. (1993). Molecular mechanisms of cardiac growth and hypertrophy: Myocardial growth factors and proto-oncogenes in development and disease. In Molecular Basis of Cardiology. Roberts, R. pp. 113134. London: Blackwell Scientific Publications.
  • SEPULVEDA, J.L., BELAGULI, N., NIGAM, V., CHEN, C.-Y., NEMER, M. & SCHWARTZ, R.J. (1998). GATA-4 and Nkx2.5 coactive Nkx-2 DNA binding targets: role for regulating early cardiac gene expression. Mol. Cell. Biol., 18, 34053415.
  • SMEYNE, R.J., VENDRELL, M., HAYWARD, M., BAKER, S.J., MIAO, G.G., SCHILLING, K., ROBERTSON, L.M., CURRAN, T. & MORGAN, J.L. (1993). Continuous c-fos expression precedes programmed cell death in vivo. Nature, 363, 166169.
  • SOONPAA, M.H. & FIELD, L.J. (1994). Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am. J. Physiol., 266, H1439H1445.
  • SUSIC, D., NUÑEZ, E., FROHLICH, E.D. & PRAKASH, O. (1996). Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension, 28, 265268.
  • VAN BILSEN, M. & CHEIN, K.R. (1993). Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc. Res., 27, 11401149.
  • WANG, Z.-Q., OVITT, C., GRIGORIADIS, A.E., MÖHLE-STEINLEIN, U., RÜTHER, U. & WAGNER, E.F., (1992). Bone and hematopoietic defects in mice lacking c-fos. Nature, 360, 741745.
  • ZIERHUT, W. & ZIMMER, H.-G. (1989). Significance of myocardial α- and β-adrenoreceptors in catecholamine-induced cardiac hypertrophy. Cir. Res., 65, 14171425.